» Articles » PMID: 27195022

Examination of the Effects of Campylobacter Concisus Zonula Occludens Toxin on Intestinal Epithelial Cells and Macrophages

Overview
Journal Gut Pathog
Publisher Biomed Central
Specialty Gastroenterology
Date 2016 May 20
PMID 27195022
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Campylobacter concisus is a Gram-negative bacterium that is associated with inflammatory bowel disease (IBD). Some C. concisus strains carry zonula occludens toxin (zot) gene which has polymorphisms. This study investigated the effects of C. concisus Zot on intestinal epithelial cells and macrophages using cell line models.

Methods: Campylobacter concisus zot (808T) gene, a polymorphism that is associated with active IBD, was cloned and expressed in Escherichia coli. The effects of C. concisus Zot on intestinal epithelial barrier were examined using Caco-2 cell model. Apoptosis induced by C. concisus Zot in Caco-2 cells was assessed by measuring the levels of caspase 3/7. The production of pro-inflammatory cytokines induced by C. concisus Zot in HT-29 cells and in THP-1 macrophage-like cells was measured using ELISA kits. Whether exposure to C. concisus Zot can affect the responses of macrophages to E. coli K12 was also investigated.

Results: Campylobacter concisus Zot caused prolonged intestinal epithelial barrier damage, induced intestinal epithelial cell apoptosis, induced epithelial production of TNF-α and IL-8 and upregulated TNF-α in THP-1 macrophage-like cells. Pre-exposure to C. concisus Zot significantly enhanced the production of TNF-α and IL-8 as well as phagocytosis by THP-1 macrophage-like cells in response to E. coli K12.

Conclusion: This study suggests that C. concisus Zot may have enteric pathogenic potential by damaging intestinal epithelial barrier, inducing intestinal epithelial and macrophage production of proinflammatory cytokines in particular TNF-α and enhancing the responses of macrophages to other enteric bacterial species.

Citing Articles

Human macrophage response to the emerging enteric pathogen : Inflammation, apoptosis, and downregulation of histones.

Naidovski N, Chong S, Liu F, Riordan S, Wehrhahn M, Yuwono C Virulence. 2024; 16(1):2440554.

PMID: 39663607 PMC: 11702953. DOI: 10.1080/21505594.2024.2440554.


Decursin protects against DSS-induced experimental colitis in mice by inhibiting the cGAS-STING signaling pathway.

Wang J, Wang Y, Huang C, Chen Y, Li X, Jiang Z Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39520553 DOI: 10.1007/s00210-024-03589-4.


sp. nov., isolated from cattle and feral swine.

Miller W, Chapman M, Williams T, Wood D, Bono J, Kelly D Int J Syst Evol Microbiol. 2024; 74(10).

PMID: 39374062 PMC: 11457942. DOI: 10.1099/ijsem.0.006524.


The oral-gut microbiome axis in inflammatory bowel disease: from inside to insight.

Wang A, Zhai Z, Ding Y, Wei J, Wei Z, Cao H Front Immunol. 2024; 15:1430001.

PMID: 39131163 PMC: 11310172. DOI: 10.3389/fimmu.2024.1430001.


Analysis of global genomes revealed that strains carrying T6SS are more common in human gastroenteritis than in environmental sources and are often phylogenetically related.

Chong S, Liu F, Yuwono C, Tay A, Wehrhahn M, Riordan S Microb Genom. 2024; 10(5).

PMID: 38814176 PMC: 11165597. DOI: 10.1099/mgen.0.001258.


References
1.
Mahendran V, Tan Y, Riordan S, Grimm M, Day A, Lemberg D . The prevalence and polymorphisms of zonula occluden toxin gene in multiple Campylobacter concisus strains isolated from saliva of patients with inflammatory bowel disease and controls. PLoS One. 2013; 8(9):e75525. PMC: 3781098. DOI: 10.1371/journal.pone.0075525. View

2.
Ismail Y, Lee H, Riordan S, Grimm M, Zhang L . The effects of oral and enteric Campylobacter concisus strains on expression of TLR4, MD-2, TLR2, TLR5 and COX-2 in HT-29 cells. PLoS One. 2013; 8(2):e56888. PMC: 3577652. DOI: 10.1371/journal.pone.0056888. View

3.
Ohkusa T, Yoshida T, Sato N, Watanabe S, Tajiri H, Okayasu I . Commensal bacteria can enter colonic epithelial cells and induce proinflammatory cytokine secretion: a possible pathogenic mechanism of ulcerative colitis. J Med Microbiol. 2009; 58(Pt 5):535-545. PMC: 2887547. DOI: 10.1099/jmm.0.005801-0. View

4.
Breese E, Michie C, Nicholls S, Murch S, Williams C, Domizio P . Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology. 1994; 106(6):1455-66. DOI: 10.1016/0016-5085(94)90398-0. View

5.
Komatsu M, Kobayashi D, Saito K, Furuya D, Yagihashi A, Araake H . Tumor necrosis factor-alpha in serum of patients with inflammatory bowel disease as measured by a highly sensitive immuno-PCR. Clin Chem. 2001; 47(7):1297-301. View